Value sets supporting cohort definitions. Listing of value sets is in alphabetical order. Some value sets refer to an outside source or repository, and others are expanded here.

BCG Vaccine Products for Intravesical Use​ VS

​ Scope/Purpose: Identifies BCG vaccine products for intravesical use

Inclusions: Live BCG for intravesical use

Exclusions: None

CodeDescriptionCode SystemVersionStatus
90586Bacillus Calmette-Guerin vaccine (BCG) for bladder cancer, live, for intravesical use​​HCPCS​2019ABActive
​19Bacillus Calmette-Guerin vaccineCVXActive

Confirmed COVID-19 Infection VS

Location: VSAC

OID: 2.16.840.1.113762.1.4.1032.117

Code Systems: ICD10CM, SNOMEDCT

Type: Grouping

Convalescent Serum of COVID-19 Products VS


Famotidine VS


Hydroxychloroquine VS

Location: VSAC

OID: 2.16.840.1.113762.1.4.1032.127

Code Systems: RxNORM

Type: Extensional

Intravesical Administration of BCG Procedure VS

Scope/Purpose: Identifies procedures for intravesical administration of live BCG vaccine. Used to identify patients who received BCG as cellular therapy for bladder cancer.

Inclusions: Procedures specific to the administration of live BCG into the bladder​ (active and inactive terms)

Exclusions: Procedures not specific to BCG​ AND Administration of BCG other than in the intravesical space

CodeDescriptionCode SystemVersionStatus
J9031Bcg (intravesical) per instillation​HCPCS​2020Inactive
J9030​Bcg live intravesical instillation, 1 mg​HCPCS2020​Active
​301879009​Instillation of bacillus Calmette-Guerin into the bladder (procedure)​SNOMED CT202003​Active

Intravesical Administration of Therapeutic Agent Procedure VS

Scope/Purpose: Identifies procedures indicative of intravesical administration of therapeutic agent.

Inclusions: Procedures representing the administration of unspecified therapeutic agent into bladder

Exclusions: Procedures specific to BCG (covered by Intravesical Administration of BCG Procedure VS)

CodeDescriptionCode SystemVersionStatus
51720Bladder instillation of anticarcinogenic agent (including retention time)​CPT​2019ABActive
​44194005Urinary bladder instillation of anticarcinogenic agent (procedure)​SNOMED CT202003​Active
​712753009Administration of chemotherapeutic agent into bladder via intravesical route (procedure)SNOMED CT202003​Active

Invasive Mechanical Ventilation VS


PCR SARSCoV-2 Qualitative Test

The set of LOINC codes appearing on under category #1 (SARS-CoV-2 nucleic acids (RNA)), with type "qualitative" and method "Nucleic acid amplification with non-probe-based detection, such as melt curve analysis" or method "Nucleic acid amplification with probe-based detection"

Remdesivir VS


Respiratory Condition VS

Scope/Purpose: Identifies patients with signs and symptoms of respiratory problems

Location: Not published

Code Systems: ICD-10-CM

Code Range: J00-J99

SARS Coronavirus 2 Qualitative Laboratory Test VS

Location: VSAC

OID: 2.16.840.1.113762.1.4.1032.109

Code System: LOINC

Type: Extensional

SARS Related Qualitative Laboratory Test VS

Location: VSAC

OID: 2.16.840.1.113762.1.4.1032.113

Location: VSAC

Code System: LOINC

Type: Extensional